SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-22-035341
Filing Date
2022-12-14
Accepted
2022-12-13 19:26:47
Documents
5

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 201536
2 ex6.htm EX-1 113112
3 ex7.htm EX-7 1999
4 ex7_001.jpg GRAPHIC 443593
5 ex7_002.jpg GRAPHIC 245817
  Complete submission text file 0001493152-22-035341.txt   1267688
Mailing Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022
Business Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022 914-629-8496
Camac Fund, LP (Filed by) CIK: 0001516478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92867 | Film No.: 221460906
SIC: 2834 Pharmaceutical Preparations